Highest-scoring questions on the site.
Conditions: ecnoglutide · 3.33 mg/mL. I have done this once and I suspect I got away with it rather than got it right. For context: I keep records of every batch,…
Numbers first: cagrilintide · six weeks · 25 °C. I can predict the outcome but I cannot explain it, which means I will get the next case wrong. I would like to know…
Conditions: a U-40 insulin syringe · 5 mg/mL. I think I have a problem. I am not yet sure whether it is a real problem or a measurement artefact. I want to know…
For reference: 98.4% · ecnoglutide. I would like the arithmetic checked rather than the conclusion asserted. I have deliberately not used an online calculator because…
Numbers first: an 18G drawing needle · orforglipron · 20 mg/mL. I want to know what the trade-off actually is rather than which option is fashionable. I would rather…
This is my second independent submission on material from the same supplier. I suspect the usual explanation for this is wrong, or at least incomplete. I am aware…
What I have: eight · 1,000 kcal. This is a planning question. I know what my options are; I do not know how to weigh them. What I want is the minimum viable version,…
Numbers first: Wuxi · Singapore. I can parse the result. I am less sure what it licenses me to conclude. I have deliberately not looked at anyone else’s…
Details up front: a U-100 insulin syringe · 10 mg · 2 mg/mL. This should be a straightforward calculation and I keep getting two different answers. The numbers are…
For reference: 98.2% · a wide-pore C18 column · a GLP-1 receptor agonist. I want to understand what this actually establishes, as opposed to what it is being used to…
Numbers first: Wuxi · Ireland. I can parse the result. I am less sure what it licenses me to conclude. I have deliberately not looked at anyone else’s interpretation…
Numbers first: a GLP-1 receptor agonist · twenty-one days. I can do the algebra. I am not confident about the conversion factors. If there is a standard way to lay…
The specifics, since they change the answer: MKM · survodutide. An unexpected observation, and I would like a differential rather than reassurance. The conditions…
Numbers first: 99.1% · purity figure. I can parse the result. I am less sure what it licenses me to conclude. I have deliberately not looked at anyone else’s…
The particulars: SURPASS-3 · ecnoglutide. Somebody stated this to me confidently and I would like to check it before repeating it. I would accept a well-reasoned…
Concretely: semaglutide · 37 °C · twenty-one days. The failure mode I am trying to avoid is making this decision emotionally. I have twelve months in view and I would…
I want the floor, not the optimum. I am losing about 0.9 kg a week on tirzepatide and I have limited capacity to train: realistically two sessions a week, 40 minutes…
I have three data points across nine months, which I hope is enough to see a trend. I understand the observation; what I do not understand is the mechanism behind it.…
The specifics, since they change the answer: 98.8% · PeptideMeter · 97.6% · Janoshik. The comparison I want does not seem to exist anywhere in a form I can evaluate.…
Details up front: SWB · QSC · Germany. I want to know what the trade-off actually is rather than which option is fashionable. I would rather have a defensible reason…
The particulars: STEP 5 · hair thinning · 8 mg. I want to understand what this actually establishes, as opposed to what it is being used to imply. My concern is that…
The particulars: Changsha · New Zealand. I have the document in front of me and I can read the numbers. What I cannot do is interpret them. I am reasonably…
The particulars: 81 kg · 800 kcal. I would like the arithmetic checked rather than the conclusion asserted. I have deliberately not used an online calculator because…
Numbers first: mazdutide · 1 mg/mL · two weeks. I am asking for verification rather than opinion, ideally with something I can read myself. It is possible the…